A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease
Biology of Blood and Marrow Transplantation · 2020-05 · 26 (5) · 835-844
DOI: 10.1016/j.bbmt.2019.08.029 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift Biology of Blood and Marrow Transplantation, 2020-05. Verfasst von Partow Kebriaei und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stem Cell and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: pkebriae@mdanderson.…. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells. Die Arbeit wurde bisher 167-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Osiris Therapeutics.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stem Cell and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: pkebriae@mdanderson.org.
- Mesoblast, New York, New York.
- Tom Baker Cancer Center, University of Calgary, Calgary, Alberta, Canada.
- Barbara Ann Karmanos Cancer Institute, Detroit, Michigan.
- University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom.
- Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Förderung
- NCI NIH HHS
- Osiris Therapeutics
Zitieren
APA
Kebriaei, P., Hayes, J., Daly, A., Uberti, J., Marks, D. I., Soiffer, R., Waller, E. K., Burke, E., Skerrett, D., Shpall, E., & Martin, P. J. (2020). A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation, 26(5), 835-844. https://doi.org/10.1016/j.bbmt.2019.08.029
Vancouver
Kebriaei P, Hayes J, Daly A, Uberti J, Marks DI, Soiffer R, et al. A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 2020;26(5):835-844. doi:10.1016/j.bbmt.2019.08.029
BibTeX
@article{Kebriaei2020,
author = {Kebriaei, Partow and Hayes, Jack and Daly, Andrew and Uberti, Joseph and Marks, David I and Soiffer, Robert and Waller, Edmund K and Burke, Elizabeth and Skerrett, Donna and Shpall, Elizabeth and Martin, Paul J},
title = {A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease},
journal = {Biology of Blood and Marrow Transplantation},
year = {2020},
volume = {26},
number = {5},
pages = {835--844},
doi = {10.1016/j.bbmt.2019.08.029}
}
EUVIMED